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costs by reducing unnecessary hospitalization and medication
for patients with ‘false-positive’ initial AFB smears.
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Abstract
As a novel antibiotic resistance determinant, investigation of the
occurrence and characteristics of class 1 integron was performed
on nosocomial methicillin-resistant Staphylococcus aureus (MRSA)
strains sampled during 2001–2006. Seventy-six out of 179 (42.5%)
of the tested strains were found to carry class 1 integrons, with
four unique arrays of gene cassettes detected. This is the first
report of the comprehensive identification and typing of class 1 in-
tegrons in clinical MRSA isolates over a 6-year period, represent-
ing the first evidence for class 1 integrons as possible antibiotic
resistance determinants in clinical MRSA strains.
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TABLE 1. Phenotypic and genotypic characteristics of 76 integron-bearing MRSA strains
Strain Isolation year
Class 1 integron SCCmec
RAPD-PCR Resistance profile3¢CS Gene cassette ccr mec
010808 2001 + dfrA12-orfF-aadA2 3 A AAA AcAmChCaCeCiClEGLOTcTs
010912 + dfrA12-orfF-aadA2 3 A AAA AcAmChCaCeCiClEGLOTcTs
011000* + dfrA12-orfF-aadA2 3 A AAA AcAmChCaCeCiClEGLOTcTs
011001* + dfrA12-orfF-aadA2 3 A BBB AcChCaCeCiClELOTs
011016* + dfrA12-orfF-aadA2 3 A CBC AcCeCiEGLOTs
011024* ) dfrA12-orfF-aadA2 3 A AAA AcAmChCaCeCiClEGLOTc
011025 + dfrA12-orfF-aadA2 3 A CBC AcCeCiEGLOTs
011045* + dfrA12-orfF-aadA2 3 A AAA AcAmChCaCeCiClEGLOTcTs
011052* + dfrA12-orfF-aadA2 3 A AAA AcAmChCaCeCiClEGLOTcTs
011055* + dfrA12-orfF-aadA2 3 A BBB AcChCaCeCiClELOTs
011058* + dfrA12-orfF-aadA2 3 A BBB AcChCaCeCiClELOTs
011083* + dfrA12-orfF-aadA2 3 A AAA AcAmChCaCeCiClEGLOTcTs
011098* + dfrA12-orfF-aadA2 3 A CBC AcCeCiEGLOTs
021138 2002 + dfrA12-orfF-aadA2 3 A AAA AcAmChCaCeCiClEGLOTcTs
021153 + dfrA12-orfF-aadA2 3 A DAA AcCaCeClOTcTs
021206* + dfrA12-orfF-aadA2 3 A DAA AcCaCeClOTcTs
021207* + dfrA12-orfF-aadA2 3 A DAA AcCaCeClOTcTs
021238* + dfrA12-orfF-aadA2 3 A AAA AcAmChCaCeCiClEGLOTcTs
021261* + dfrA12-orfF-aadA2 3 A BBB AcChCaCeCiClELOTs
021266* + dfrA12-orfF-aadA2 3 A CBC AcCeCiEGLOTs
021267* + dfrA12-orfF-aadA2 3 A AAA AcAmChCaCeCiClEGLOTcTs
021268* + dfrA12-orfF-aadA2 3 A CBC AcCeCiEGLOTs
021296 ) dfrA12-orfF-aadA2 3 A CBC AcCeCiEGLOTs
021542 + dfrA12-orfF-aadA2 3 A AAA AcAmChCaCeCiClEGLOTcTs
031788 2003 + dfrA12-orfF-aadA2 3 A BBB AcChCaCeCiClELOTs
032142 + dfrA12-orfF-aadA2 3 A BBB ChCaCeCiClELOTs
032267 + dfrA12-orfF-aadA2 3 A AAA AcAmChCaCeCiClEGLOTcTs
032371 + dfrA12-orfF-aadA2 3 A DAA AcCaCeClOTcTs
032423 + aacA4-cmlA1 3 A AAE AcAmChCaCeClEGLOTc
032439 + dfrA17-aadA5 3 A AAF AcAmChCaCeCiClEGLOTs
032449 + aacA4-cmlA1 3 A AAE AcAmChCaCeClEGLOTc
042470 2004 + aadA2 3 A AAA AcAmChCaCeCiClEGLOTcTs
042497 + aadA2 3 A AAA AcAmChCaCeCiClEGLOTcTs
042547 + aadA2 3 A FEI AcAmCaCeCiClEGLOTcTs
042564 + dfrA12-orfF-aadA2 3 A FEI AcAmCaCeCiClEGLOTcTs
042637 + aadA2 3 A GEJ AcAmChCaCeCiClGLOTcTs
042649 + aadA2 3 A GEJ AcAmChCaCeCiClGLOTcTs
042772 + aadA2 3 A FEI AcAmCaCeCiClEGLOTcTs
042848 + dfrA12-orfF-aadA2 3 A AAA AcAmChCaCeCiClEGLOTcTs
042885 + dfrA12-orfF-aadA2 3 A AAA AcAmChCaCeCiClEGLOTcTs
042887 + dfrA12-orfF-aadA2 3 A AAA AcAmChCaCeCiClEGLOTcTs
042898 + dfrA12-orfF-aadA2 3 A FEI AcAmCaCeCiClEGLOTcTs
042923 + dfrA12-orfF-aadA22 3 A FEI AcAmCaCeCiClEGLOTcTs
042954 + dfrA12-orfF-aadA2 3 A FEI AcAmCaCeCiClEGLOTcTs
042966 + dfrA12-orfF-aadA2 3 A FEI AcAmCaCeCiClEGLOTcTs
043000 + dfrA12-orfF-aadA2 3 A FEI AcAmCaCeCiClEGLOTcTs
053001 2005 + aadA2 3 A FEI AcAmCaCeCiClEGLOTcTs
053059 + aadA2 3 A FEI AcAmCaCeCiClEGLOTc
053147 + aadA2 3 A FEI AcAmCaCeCiClEGLOTcTs
053182 + aadA2 3 A FEI AcAmCaCeCiClEGLOTcTs
053224 + aadA2 NT NT GEJ AmChCaCeCiClGLTcTs
053332 ) aadA2 3 A GEJ AcAmChCaCeCiClGLOTc
053333 + aadA2 3 A GEJ AcAmChCaCeCiClGLOTcTs
053401 + aadA2 3 A FEI AcAmCaCeCiClEGLOTcTs
053423 + aadA2 3 A GEJ AcAmChCaCeCiClGLOTcTs
053443 + aadA2 3 A GEJ AcAmChCaCeCiClGLOTc
053444 + aadA2 3 A GEJ AcAmChCaCeCiClGLOTcTs
053474 + aadA2 3 A FEI AcAmCaCeCiClEGLOTcTs
053564 + aadA2 3 A FEI AcAmCaCeCiClEGLOTcTs
053610 + aadA2 3 A FEI AcAmCaCeCiClEGLOTcTs
053658 + aadA2 3 A FEI AcAmCaCeCiClEGLOTcTs
053685 + aadA2 3 A FEI AcAmCaCeCiClEGLOTcTs
053845 + aadA2 3 A FEI AcAmCaCeCiClEGLOTc
053899 + aadA2 3 A FEI AcAmCaCeCiClEGLOTcTs
064043 2006 + aadA2 3 A FEI AcAmCaCeCiClEGLOTcTs
064050 + aadA2 3 A GEJ AcAmChCaCeCiClGLOTcTs
064064 + aadA2 3 A FEI AcAmCaCeCiClEGLOTcTs
064100 + aadA2 3 A FEI AcAmCaCeCiClEGLOTcTs
064163 + aadA2 3 A GEJ AcAmChCaCeCiClGLOTc
064221 + aadA2 3 A GEJ AcAmChCaCeCiClGLOTcTs
064249 + aadA2 3 A GEJ AcAmChCaCeCiClGLOTcTs
064278 + aadA2 3 A GEJ AcAmChCaCeCiClGLOTcTs
064375 + aadA2 3 A GEJ AcAmChCaCeCiClGLOTcTs
065212 + aadA2 3 A GEJ AcAmChCaCeCiClGLOTcTs
065217 + aadA2 3 A GEJ AcAmChCaCeCiClGLOTc
065260 + aadA2 3 A GEJ AcAmChCaCeCiClGLOTcTs
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TABLE 2. Association between in-
tegron-bearing and non-integron-
bearing MRSA strainsCharacteristics
Value for group
p value OR (95% CI)I-MRSA Non I–MRSA
Gender
Female 26 (34.2) 39 (37.9) 0.615 1.172 (0.631–2.176)
Male 50 (65.8) 64 (62.1)
Age (mean [95% CI]) 56 (37–76) 53 (34–78)
Department
Internal medicine 39 (51.3) 60 (58.4) 0.356 1.324 (0.729–2.403)
Surgery 11 (14.5) 9 (8.7) 0.229 0.566 (0.222–1.443)
Obstetrics and Gynaecology 4 (5.3) 5 (4.9) 1.000 0.918 (0.238–3.541)
Neurology 7 (9.2) 9 (8.7) 0.913 0.944 (0.335–2.658)
Paediatrics 4 (5.3) 5 (4.9) 1.000 0.918 (0.238–3.541)
Orthopaedics 5 (6.6) 7 (6.8) 0.954 1.035 (0.316–3.396)
Department of Infectious Disease 3 (3.9) 4 (3.9) 1.000 0.983 (0.213–4.528)
General ward 3 (3.9) 4 (3.9) 1.000 0.983 (0.213–4.528)
Infection site
Bloodstream 7 (9.2) 5 (4.9) 0.249 0.503 (0.153–1.650)
Respiratory tract 19 (25.0) 30 (29.1) 0.541 1.233 (0.630–2.412)
Skin and soft tissue 35 (46.1) 46 (44.6) 0.853 0.945 (0.521–1.714)
Urinary tract 8 (10.5) 11 (10.7) 0.974 1.016 (0.388–2.663)
Other 7 (9.2) 11 (10.7) 0.747 1.179 (0.435–3.196)
Length of hospital stay (days)
Mean 26.2 23.4
Median 15.4 13.8
Range 0–178 0–152
Resistance to antibiotics
AMC 74 (97.4) 93 (90.3) 0.061 0.251 (0.053–1.183)
AMK 60 (78.9) 50 (48.5) <0.001 0.252 (0.128–0.493)
CAZ 70 (92.1) 87 (84.5) 0.124 0.466 (0.173–1.254)
CEF 76 (100) 97 (94.2) 0.085
CHL 43 (56.6) 47 (45.6) 0.148 0.644 (0.355–1.170)
CIP 70 (92.1) 87 (84.5) 0.124 0.466 (0.173–1.254)
CLI 70 (92.1) 90 (87.4) 0.310 0.593 (0.215–1.640)
ERY 55 (72.4) 52 (50.5) 0.003 0.389 (0.207–0.734)
GEN 66 (86.8) 60 (58.3) <0.001 0.211 (0.098–0.457)
LEV 72 (94.7) 90 (87.4) 0.097 0.385 (0.120–1.230)
OXA 75 (98.7) 97 (94.2) 0.251 0.216 (0.025–1.829)
SXT 67 (88.2) 40 (38.8) <0.001 0.085 (0.038–0.190)
TET 63 (82.9) 54 (52.4) <0.001 0.227 (0.112–0.463)
SCCmec type
II 0 (0) 3 (2.9)
III 75 (98.7) 93 (90.3)
NT 1 (1.3) 7 (6.8)
RAPD type
AAA-ST239-WGKAOMQ(t037)-HIJKL 17 (22.4) 0 (0)
BBB-ST239-WGKAQQ(t030)-HIJKL 6 (7.9) 2 (1.9)
CBC-ST239-WGKAQQ(t030)-HIJKL 6 (7.9) 3 (2.9)
BBD-ST239-WGKAOMQ(t037)-HIJKL 0 (0) 18 (17.5)
BAD-ST239-WGKAOMQ(t037)-HIJKL 0 (0) 2 (1.9)
CAC-ST239-WGKAOMQ(t037)-HIJKL 0 (0) 3 (2.9)
DAA-ST239-WGKAOMQ(t037)-HIJKL 4 (5.2) 0 (0)
AAE-ST239-WGKAOMQ(t037)-HIJKL 2 (2.6) 0 (0)
AAF-ST239-WGKAOMQ(t037)-HIJKL 1 (1.3) 0 (0)
BCD-ST239-WGKAOMQ(t037)-HIJKL 0 (0) 6 (5.8)
EDH-ST239-WGKAOMQ(t037)-HIJKL 0 (0) 27 (26.2)
FEI-ST239-WGKAOMQ(t037)-HIJKL 23 (30.3) 0 (0)
EDG-ST239-WGKAOMQ(t037)-HIJKL 0 (0) 38 (36.9)
GEJ-ST239-WGKAOMQ(t037)-HIJKL 17 (22.4) 0 (0)
HFK-ST239-WGKAOMQ(t037)-HIJKL 0 (0) 2 (1.9)
HFL-ST239-WGKAOMQ(t037)-HIJKL 0 (0) 2 (1.9)
Total 76 103
Value group: values are number of patients or strains. Values in parentheses are percentages.
Infection sites: blood culture specimens included blood inoculated into aerobic and/or anaerobic blood culture med-
ium. Tracheal secretion specimens included secretions from the trachea and bronchia and bronchoalveolar lavage
fluid specimens. Wound specimens included surgical wound specimens but also specimens from ulcers, fistulae,
abscesses, drainage fluids, catheter sites, percutaneous endoscopic gastrostomy insertion sites, and tracheostomas.
Urine contained native urine from urinary catheters or bladder puncture and inoculated culture systems. Other spec-
imens consisted of skin swab specimens (from the nares, axilla, groin or perianal area), as well as swab specimens of
the throat, tonsils, eye, ear and vagina, body liquids, and puncture exudates.
Resistance to antibiotics: AMC, amoxicillin/clavulanic acid; AMK, amikacin; CAZ, ceftazidime; CEF, cefazolin; CHL, chl-
oramphenicol; CIP, ciprofloxacin; CLI, clindamycin; ERY, erythromycin; GEN, gentamicin; LEV, levofloxacin; OXA,
oxacillin; SXT, trimethoprim-sulfamethoxazole; TET, tetracycline.
RAPD type: each RAPD type consisted of RAPD-PCR (the three-letter code summarizes the typing results per
primer used; in detail, first digit, primer 1; second digit, primer 7; third digit, primer E2; data represented by a capital
letter given in a certain column may be different from the same character in another column), MLST, spaA and coa
types.
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Indiscriminate use of existing antibiotics can lead to the pro-
liferation of antibiotic resistance, which poses a dilemma for
the future treatment of bacterial infections [1]. Despite a
variety of therapeutic options and novel drug discovery
efforts, antibiotic resistance in microbes still remains a major
public health concern for the treatment of infectious dis-
eases. One such infectious organism is methicillin-resistant
Staphylococcus aureus (MRSA), a gram-positive coccus that
has been recently labelled as a ‘super bug’ due to its wide-
spread resistance to commonly used antibiotics [2]. China
remains one of the worst areas for antibiotic abuse; as a
consequence, biosafety and general concerns regarding the
threat of unleashing waves of ‘Super Bugs’ in China have
raised the necessity for surveillance and investigation of anti-
biotic resistance mechanisms involved in clinical MRSA. Since
its first discovery in 1961, MRSA has become one of the
most prevalent pathogens causing nosocomial infections
throughout the world [3,4]. A mobile genetic element, desig-
nated staphylococcal cassette chromosome mec (SCCmec),
plays a major role in causing resistance among MRSA [5].
Another novel mobile genetic element, the integron, is
potentially the primary agent in dissemination of multidrug
resistance among bacteria [6]. However, most studies on
integrons were limited to gram-negative microorganisms, and
investigation of integrons in gram-positive bacteria, especially
MRSA, still remains unclear. In a previous study, we screened
the class 1 integron in 46 gram-positive clinical strains iso-
lated from an outbreak at the First Affiliated Hospital of
Jinan University (FAHJU), including 17 S. aureus and 20 coag-
ulase-negative staphylococci (CoNS) strains, with a positive
identification rate of 100% [7]. Based on this novel observa-
tion and previously unnoticed spread of the class 1 integron
in S. aureus, this study aimed to investigate the occurrence
and prevalence of MRSA-associated class 1 integron in the
same hospital setting during 2001–2006.
A total of 179 MRSA strains isolated from FAHJU were
identified as S. aureus by the API Staph strip test and Vitek 2
automated system; methicillin resistance was determined by
latex agglutination for PBP2a and mecA detected by PCR
[8,9]. Antimicrobial susceptibility testing and PCR identifica-
tion of staphylococcal enterotoxins (sea, seb, sec, sed, see),
exfoliative toxins A, B (eta, etb), TSST-1 (tst), and Panton-
Valentine leukocidin (lukS and lukF) genes were performed
[8,10,11]. All strains were screened for class 1 integrons and
characterized for variable regions. Briefly, the intI gene, vari-
able region and 3¢CS were examined using primer sets intI1-
U with intI1-D, intI1-K with In-B, and qacE41-F with sul1-B,
respectively [1,12]. PCR products of the variable region were
characterized by restriction fragment length polymorphism
(RFLP) and further confirmed by sequencing. SCCmec typing
and random amplified polymorphic DNA (RAPD)-PCR were
then performed, with at least one strain representative of
each RAPD type selected randomly for further analyses by
MLST, spa and coa typings [5,13–17].
The multidrug resistance rate, which was defined as resis-
tance to at least seven of the tested antimicrobials, was
93.8% (168/179), with negative PCR amplification for exo-
toxin, exfoliative toxins, TSST-1 and PVL. Significant differ-
ences to amikacin, erythromycin, gentamicin, trimethoprim-
sulfamethoxazole and tetracycline were observed between
MRSA strains with and without the class 1 integron. Genetic
analyses demonstrated that class 1 integron was detected in
76 strains, with 73 carrying the 3¢-conserved region of
qacE41-sul1, and all strains contained one of four observed
unique types of gene cassette arrays (Table 1). Three and
168 strains belonged to classic nosocomial SCCmec type II
and III, with eight strains untypable. RAPD-PCR with primers
AP1, AP7 and E2 classified 179 MRSA strains into 8, 6 and
12 distinct groups, respectively, with a total of 16 RAPD
types (Table 2). Randomly selected strains fell into the
ST239-MRSA-III group (clonal complex, CC239), with coa
type HIJKL and 2 spaA types (WGKAOMQ-t037 and
WGKAQQ-t030) (Table 2).
The class 1 integron was commonly found (42.5%, 76/
179), but the incidence rate decreased over the study per-
iod, with 65.0% (13/20) in 2001, 55.0% (11/20) in 2002,
46.7% (7/15) in 2003, 44.0% (15/34) in 2004, 36.0% (18/50)
in 2005 and 30.0% (12/40) in 2006. This positive identifica-
tion rate was somewhat lower than that observed in preli-
minary studies on S. aureus (53.3%, 16/30) and CoNS (56.6%,
30/53) in south China [1,18]. Most investigations of class 1
integrons have been primarily concerned with gram-negative
bacteria; however, only four reports regarding staphylococci
were currently available, with the limitation of occasional iso-
lation or insufficient samples to comment on the epidemio-
logical significance [1,9,18,19]. To our knowledge, this is the
first report of the consistent detection of class 1 integrons
in nosocomial MRSA isolates in a large-scale longitudinal
study (6-years), representing the first definite evidence of
the class 1 integron as an unnoticed antimicrobial determi-
nant, possibly involved in the rampant spread of antibiotic
resistance mechanisms in clinical MRSA. Furthermore, it is
also the first identification of MRSA isolates simultaneously
carrying two mobile genetic elements: gene cassettes within
a class 1 integron and SCCmec, including four different
arrays of gene cassettes and two types of SCCmec. Because
integrons and SCCmec can serve as reservoirs of various
resistance genes and function to exchange genes between
species, it has been hypothesized that their simultaneous
existence may confer increased fitness and better survivability
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to bacterial strains harbouring these mobile genetic elements
in various environments. Three out of four detected gene
cassette arrays were first reported in S. aureus, with
sequences identical to those in gram-negative and gram-posi-
tive bacteria (1, 7, 9, 18). The two most frequently detected
resistance genes in class 1 integrons were of the aadA and
dfrA families, with identification rates of 97.4% (74/76) and
50.0% (38/76), respectively. Arrays dfrA12-orfF-aadA2 and
aadA2 were the most dominant in the tested strains, making
up 48.7% (37/76) and 47.4% (36/76), respectively. Cassette
array dfrA12-orfF-aadA2 was prevalent during 2001–2004 but
was undetectable from 2005, while cassette aadA2 appeared
in 2004 and dominated during 2005–2006. It is noteworthy
that the similar high prevalence of array dfrA12-orfF-aadA2
was also observed in CoNS strains during 2001–2004; how-
ever, aadA2 was scarcely found [18]. Similar to our own find-
ings, aadA2 was the only gene cassette detected in another
study from 2005 during an outbreak of S. aureus [1]. Because
the same combination and temporal pattern of identified
gene cassettes had also been characterized in staphylococci
and various gram-negative bacteria previously, further studies
are required to determine the origins of class 1 integrons in
staphylococci, and whether they can spread via interactions
with both gram-positive and gram-negative bacteria. In recent
years, community-associated MRSA (CA-MRSA) has emerged
and become prevalent in many countries and regions, often
outnumbering more traditional hospital-acquired MRSA (HA-
MRSA) infections [8,20]. As generally accepted, the indiscrim-
inate and over use of existing antibiotics is the primary cause
of the emergence and selection of antibiotic-associated
mobile genetic elements, which to some extent, is reflected
by the increase in prevalence of integrons and nosocomial
SCCmec. Although this study showed a reduction in the
prevalence of class 1 integrons over time, a large proportion
of MRSA isolates still harboured these integrons, which may
serve as reservoirs of antimicrobial resistance and virulence-
associated genes, which can contribute to increased rates of
treatment-resistant S. aureus infections in both the hospital
and community setting.
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